The gut microbiome has clear implications for health and disease. Recent evidence of this comes from a US FDA vote for approval of the microbiome-based drug RBX2660, created by Rebiotix Inc, A Ferring Company, to treat potentially deadly bacterial infections with Clostridium difficile (Cdiff). Cdiff is a common gut bacteria that may cause severe diarrhea...
A recent article in the Washington Post highlights a link between the gut microbiome composition and cancer immunotherapy treatment outcomes. The human gut microbiome consists of a vast array of bacteria, fungi, phages and other microbes. The interactions between the microbes and their interconnection with the host affects host immunity, health and homeostasis. In this...
Collaboratively administrate empowered markets via plug-and-play networks. Dynamically procrastinate B2C users after installed base benefits. Dramatically visualize customer directed convergence without revolutionary ROI. Proactively envisioned multimedia based expertise and cross-media.
© 2021 CosmosID. All rights reserved